Selective bronchodilatory effect of Rooibos tea (Aspalathus linearis) and its flavonoid, chrysoeriol

European Journal of Nutrition

Volumn 45, Issue 8, 2006, Pages 463-469

  Khan, Arif Ullah ^a   Gilani, Anwarul Hassan ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

Airway selectivity; Chrysoeriol; Hypotensive; KATP channel activator; Rooibos tea

Indexed keywords

ASPALATHUS LINEARIS EXTRACT; BRONCHODILATING AGENT; CARBOGEN; CROMAKALIM; FLAVONOID; GLIBENCLAMIDE; PLANT EXTRACT; ROOBOIS TEA; SODIUM CHLORIDE; SPASMOLYTIC AGENT; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; ASPALATHUS LINEARIS; BRONCHODILATATION; CANNULATION; CARDIOVASCULAR DISEASE; DOSE RESPONSE; DRUG EFFICACY; GASTROINTESTINAL DISEASE; HERBAL MEDICINE; IN VIVO STUDY; NONHUMAN; RABBIT; RAT; RESPIRATORY TRACT DISEASE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA; ASPALATHUS; BRONCHODILATOR AGENTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLAVONOIDS; GLYBURIDE; GUINEA PIGS; JEJUNUM; MALE; MUSCLE CONTRACTION; PLANT EXTRACTS; POTASSIUM CHANNELS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; TEA; TISSUE CULTURE TECHNIQUES; TRACHEA;

ASPALATHUS LINEARIS; CAVIA PORCELLUS; ORYCTOLAGUS CUNICULUS;

EID: 33845870385     PISSN: 14366207     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00394-006-0620-0     Document Type: Article

References (29)

1. Wyk BV, Oudtshoorn BV, Gericke N (2002) Medicinal plants of South Africa. Briza Publications, Pretoria, pp 48-49
2. Wesgro background report (2000) The Rooibos industry in the Western Cape. WESGRO, Western Cape investment and trade promotion agency, Cape Town, http://www.wesgro.org.za
3. Joubert E, Winterton P, Britz TJ, Ferreira D (2004) Superoxide anion and α,α-diphenyl-β-picrylhydrazyl radical scavenging capacity of Rooibos (Aspalathus linearis) aqueous extracts, crude phenolic fractions, tannin and flavonoids. Food Res Int 37:133-138
4. Duke JA, Bogenschutz-Godwin MJ, Du celliar J, Duke PAK (2002) Hand book of medicinal herbs, 2nd edn. CRC Press, Boca Raton, pp 612-613
5. Brown D (1995) Encyclopaedia of herbs and their uses. Dorling Kindersley, London, p 244
6. Nakano M (1997) Rooibos tea as an anti-aging beverage. Rooibos Limited, Clanwilliam, 8135
7. Inanami O, Asanuma T, Inukai N, Jin T, Shimokawa S, Kasai N, Nakano M, Sato F, Kuwabara M (1995) The supressión of age-related accumulation of lipid peroxides in rat brain by administration of Rooibos tea (Aspalathus linearis). Neurosci Lett 196:85-88
8. Marnewick J, Joubert E, Joseph S, Swanevelder S, Swart P, Gelderbolm W (2005) Inhibition of tumour promoton in mouse skin by extracts of rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia), unique Southern African herbal teas. Cancer Lett 224:193-202
9. Ulicna O, Vancova O, Bozek P, Carsky J, Sebekova K, Boor P, Nakano M, Greksak M (2006) Rooibos tea partially prevents oxidative stress in streptozotocin-induced diabetic rats. Physiol Res 55:157-164
10. Na HK, Mossanda KS, Lee JY, Surh YJ (2004). Inhibition of phorbol ester-induced COX-2 expression by some edible African plants. Biofactors 21:149-153
11. + channel activation. Basic Clin Pharm Toxicol 99:365-373
12. National Research Council (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington, pp 1-7
13. Evans WC (1996) Trease and Evan's pharmacognosy, 14th edn. WB Sounders, London, pp 161-408
14. Singleton VL, Orthofer R, Lamuela-Raventos RM (1999) Analysis of total phenols and other oxidation substrates and oxidants by means of Folin-Ciocalteu Reagent. Methods in Enzymol 299:152-178
15. Huang DJ, Lin CD, Chen HJ, Lin YH (2004) Antioxidant and antiproliferative activaties of sweet potato (Ipomoea batatas [L.] Lam 'Tainong 57') constituents. Bot Bull Acad Sin 45:179-186
16. Gilani AH, Shah AJ, Ghayur MN, Majeed K (2005a) Pharmacological basis for the use of turmeric in gastrointestinal and respiratory disorders. Life Sci 76:3089-3105
17. + channels in rat ileal smooth muscle. Eur J Pharmacol 271:379-386
18. Quest U (1992) Potassium channel openers: Pharmacological and clinical aspects. Fund Clin Pharmacol 6:279-293
19. Pelaia G, Gallell L, Vatrella A, Grembiale RD, Maselli R, De Sarro GB, Marsico SA (2002) Potential role of potassium channel openers in the treatment of asthma and chronic obstructive pulmonary disease. Life Sci 70:977-990
20. Hamilton TC, Weir SW, Weston TH (1986) Comparison of the effects of BRL34915 and verapamil on electrical and mechanical activity in rat portal vein. Br J Pharmacol 88:103-111
21. ATP channels. Physiol Rev 78:227-245
22. Weston AH, Edwards G (1992) Recent progress in potassium channel opener pharmacology. Biochem Pharmacol 43:47-54
23. 2. Gen Pharmacol 29:847-857
24. Sanchez de Rojas, Somoza VR, Ortega BT, Villar AM (1996) Isolation of vasodilatory active flavonoids from the traditional remedy Satureja obovata. Planta Med 62:272-274
25. +-channel activity and contractile behavior in mammalian ventricles by the potassium channel openers: cromakalim and RP49356. J Pharmacol Exp Ther 255:429-435
26. + conductance of heart cell membrane by BRL 34915. Naunyn Schmiedeberg's Arch Pharmacol 33:93-97
27. McPherson GA, Angus JA (1990) Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists. Br J Pharmacol 100:201-206
28. ATP channels in transgenic mice expressing dominant negative Kir6 subunits. Am J Physiol Heart Circ Physiol 291:H543-H551
29. ATP channel openers. EMBO J 19:6644-6651